CerviGuard proof
Live workspace, repository, and MDR draft are visible.
Visitors can review CerviGuard through its live workspace, public repository, screenshots, MDR draft, and trust material.
SmartClover builds healthcare AI where clinical work actually happens. CerviGuard helps cervical-screening teams structure intake, review cases with AI support, coordinate triage, and manage clinician-led follow-up.

SmartClover links the live CerviGuard workflow to research context, trust material, and direct commercial paths for clinics, research partners, and investors.

CerviGuard proof
Visitors can review CerviGuard through its live workspace, public repository, screenshots, MDR draft, and trust material.
Research context
Two PubMed references are linked for visitors who want context on cervical screening participation and follow-up work in Romania.
Research track
DataGems gives research partners a concrete surface for synthetic-data workflow discussions after the CerviGuard path is clear.
CerviGuard is the product teams review first. DataGems and the deployment services are the research and infrastructure conversations that follow.
Flagship product
A live product for structured cervical screening workflows, AI-assisted review, and clinician-led follow-up.
Live research pilot
A live research pilot for synthetic-data workflows, schema drafting, configured generation jobs, and reviewable exports.
Public research directions
SmartClover publicly discusses cancer prevention, secondary prophylaxis, early detection, and treatment-optimization research as active directions, not as released products.
Founder and research credibility
Founder Dr. Andreea Damian leads SmartClover from Cluj-Napoca with CerviGuard as the flagship product. The research links below are kept as context for the cervical-screening problem space; current product details come from CerviGuard, product, and trust pages.
Source-linked materials
These milestones connect the published screening research, the CerviGuard build, and how SmartClover works today.
2017 publication
Social Science & Medicine published field research on Roma women and cervical screening participation in Romania.
2022 publication
BMJ Open published a protocol on facilitators and barriers to follow-up after abnormal cervical screening results in remote Romanian communities.
2024-2026 product build-out
The public product surface, repository, and model hub provide a concrete flagship proof layer with supporting artifacts.
Current routes
Contact, pricing, how-to-buy, proof, regulatory, and trust routes help each visitor decide where to start.
The site keeps one primary CTA while making audience-specific entry points clear for buyers, partners, and investors.
For clinics, hospitals, and operators evaluating CerviGuard or a scoped product rollout.
Go to contact hubFor institutions exploring prevention, qualitative research, or model-development collaboration.
Go to contact hubFor investors and accelerators reviewing SmartClover's healthcare AI platform and public product evidence.
Go to contact hubEverything a buyer, partner, or investor needs to vet SmartClover before reaching out.